We are live on ! Find out more
VKTX icon

Viking Therapeutics
VKTX

134 hedge funds and large institutions have $238M invested in Viking Therapeutics in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 40 increasing their positions, 47 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

476% more call options, than puts

Call options by funds: $8.98M | Put options by funds: $1.56M

5% more capital invested

Capital invested by funds: $227M → $238M (+$11M)

0.19% less ownership

Funds ownership: 48.49% → 48.3% (-0.19%)

3% less funds holding

Funds holding: 138 → 134 (-4)

15% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 47

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
40
Reduced
47
Closed
12
Calls
$8.98M
Puts
$1.56M
Net Calls
+$7.42M
Net Calls Change
+$1.98M

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$5.13M
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$2.66M
3
ACH
ArrowMark Colorado Holdings
Colorado
+$1.99M
4
UBS Group
UBS Group
Switzerland
+$635K
5
First Trust Advisors
First Trust Advisors
Illinois
+$611K

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$5.83M
2
Citigroup
Citigroup
New York
-$1.21M
3
Morgan Stanley
Morgan Stanley
New York
-$1.18M
4
Goldman Sachs
Goldman Sachs
New York
-$935K
5
ACM
ACT Capital Management
Pennsylvania
-$770K
Name Holding Trade Value Shares
Change 		Change in
Stake
CFGS
126
Concourse Financial Group Securities
Alabama
$1K – – –
FIA
127
FNY Investment Advisers
New York
$1K – – –
CAPTRUST Financial Advisors
128
CAPTRUST Financial Advisors
North Carolina
$1K +$1.12K +182 New
QT
129
Quantbot Technologies
New York
$1K +$1.24K +200 New
ACM
130
ACT Capital Management
Pennsylvania
– -$770K -128,500 Closed
XT
131
XTX Topco
Cayman Islands
– -$149K -24,841 Closed
VF
132
Virtu Financial
New York
– -$137K -22,929 Closed
CSS
133
Cubist Systematic Strategies
Connecticut
– -$131K -21,810 Closed
ProShare Advisors
134
ProShare Advisors
Maryland
– -$106K -17,747 Closed
HR
135
Hayden Royal
North Carolina
– -$101K -16,900 Closed
D.E. Shaw & Co
136
D.E. Shaw & Co
New York
– -$97K -16,273 Closed
VRS
137
Virginia Retirement Systems
Virginia
– -$76K -12,700 Closed
ASN
138
Advisory Services Network
Georgia
– -$3K -500 Closed
S
139
SignatureFD
Georgia
– -$1K -191 Closed
Fidelity Investments
140
Fidelity Investments
Massachusetts
– -$840 -136 -70%
EVM
141
Eaton Vance Management
Massachusetts
– -$290 -47 -32%
CFA
142
Carroll Financial Associates
North Carolina
– +$290 +47 New
2 3 4 5
6

VKTX Hedge Fund Activity: Q3 2021 in Review

134 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Viking Therapeutics (VKTX) for Q3 2021, worth a combined $238M — up 4.9% from $227M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of VKTX and 9 opened new positions — a net loss of 3 holders — while 47 trimmed existing stakes and 40 added.

The largest buyer was Nuveen, adding an estimated $5.13M. The largest seller was State Street, cutting an estimated $5.83M.

  • 134 institutional investors held Viking Therapeutics (VKTX) as of Q3 2021, down from 138 in Q2 2021.
  • Funds reported $238M of Viking Therapeutics stock for Q3 2021, up 4.9% quarter-over-quarter.
  • 9 funds opened new Viking Therapeutics positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest Viking Therapeutics buyer in Q3 2021 was Nuveen, an estimated $5.13M added.
  • The largest Viking Therapeutics seller in Q3 2021 was State Street, an estimated $5.83M sold.

Based on aggregated 13F filings for Q3 2021.